Cargando…
Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer
Mesenchymal stem-like (MSL) breast cancers are enriched for cells with tumor reconstituting and mesenchymal characteristics. These cancers are often triple-negative and have a poor prognosis. Few effective targeted treatment options exist for patients with these cancers, and even when targeted thera...
Autores principales: | Colavito, Sierra A., Platt, James T., Held, Matthew A., Liu, Zongzhi, Sokup, Ryan, Stern, David F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690678/ https://www.ncbi.nlm.nih.gov/pubmed/31448050 http://dx.doi.org/10.18632/oncotarget.27104 |
Ejemplares similares
-
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
por: Zhao, Na, et al.
Publicado: (2021) -
Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
por: Lamballe, Fabienne, et al.
Publicado: (2020) -
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy
por: Winter, Marie, et al.
Publicado: (2023) -
Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020) -
Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition
por: Garcia, Elizabeth, et al.
Publicado: (2021)